Global Autonomous Therapy System Market Research Report Segmentation By Product (Rehabilitation Robots, Surgical Robots, Hospitals and Pharmacy Robots, Emergency Response Robotics Systems, and Non-invasive radiosurgery Robots); Application (Laparoscopy, Neurology, Special Education, Orthopedics Robotics System, and Others); Region Size, Share, Growth Analysis | Forecast (2024 2030)

Market Size and Overview:

The Global Autonomous Therapy System Market size was USD 1.8 billion in 2023 and is estimated to grow to USD 3.41 billion by 2030. The market is Following a CAGR OF 9.6%

Industry Overview:

The landscape of medical robotic systems is poised for transformation in the coming years, driven by technological advancements in various domains such as high-definition surgical microscope cameras, 3D imaging, motion sensors, data loggers, motion analyzers data dynamics, and robotic catheter control systems (CCS) and remote navigation. Intuitive Surgery Inc. predominantly employs the da Vinci surgical system, which originated from a computer system capable of conducting laparoscopic surgery.

The constant evolution of medical technologies reflects the swift progress in medical robotic systems. Geisinger Health System's insurance initiative, Proven Care, offers patients guaranteed coverage post a 90-day follow-up admission, aiming to curtail surgical errors, complications, and overall surgical costs.

The future trajectory of robotics technology entails exploring novel functionalities for existing processes, expected to generate increased demand for medical robots. The market is witnessing a surge in technology transfer partnerships with third-party vendors to innovate and develop new applications for robotic systems.

As per the FDA, the use of robots in the United States surged from 25,000 to 450,000 per year between 2005 and 2012. Notably, the National Cancer Institute (NCI) estimates that by 2014, approximately 80% of surgical prostate removals utilized medical robots, compared to a mere 1% in 2001. The escalating adoption of technologically advanced robotic systems is anticipated to fuel demand in the years to come.

Impact of COVID-19 on the Autonomous Therapy System Market:

COVID-19 has emerged as a global stress test, with a rising number of infections worldwide triggering concerns about global economic growth. In 2020, the pandemic continues to unfold, propelling the popularity of robots, drones, and artificial intelligence.

The global outbreak of COVID-19 is significantly influencing the robotics industry, prompting the development of professional service robots. These robots aid in replenishing essential infrastructure staff, alleviating stress in the supply chain. Furthermore, these technologies have proven instrumental in addressing critical staffing shortages in healthcare, industry, and supply chains, while also facilitating "social distancing" and effective detection and response to the pandemic.

Market Drivers:

The escalating incidence of medication errors is propelling the growth of the market.

Medication errors, unintentional failures in drug treatment, pose health risks to patients. Common preventable causes include errors in prescribing, preparing, storing, dispensing, and administering medicines. Comprehensive and accurate Electronic Health Records (EHRs) accessible to both patients and healthcare providers ensure optimal care. The successful implementation and use of Clinical Decision Support Systems (CDSS) and complementary systems are crucial for hospitals and physicians globally, driving their widespread adoption.

Market Restraints:

Concerns about data security related to cloud based CDSS are hindering the market's growth.

The security of data stored in cloud based CDSS is a significant apprehension, as patient information is deemed sensitive and requires utmost confidentiality, accessible only to authorized users. Regulatory frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the European Data Protection Regulation in the European Union scrutinize patient information. The transfer of protected health information (PHI) outside the country of origin is restricted in many nations. While private clouds offer enhanced access protocols, the healthcare industry remains uncertain about their effectiveness, as they still face security challenges akin to traditional IT systems.

Global Autonomous Therapy System Market Segmentation:

Global Autonomous Therapy System Market Segmentation: By Product:

• Surgical Robots
• rehabilitation Robots
• Non-Invasive Radiosurgery Robots
• Hospitals and Pharmacy Robots
• Emergency Response Robotic Systems

Categorized under various products, medical robot systems include Surgical Robots, Non-Invasive Surgical Robotic Systems, Robotic Emergency Response Systems, Prosthetics, Support and Rehabilitation Systems, and Non-medical Hospital Robotics systems. In 2014, Surgical robots dominated the market, commanding a 65% market share due to the escalating adoption of robotic systems in hospitals and the surging demand for minimally invasive surgeries.

Furthermore, advancements in technology, specifically those addressing the limitations of laparoscopic surgery, such as Da Vinci surgery, are expected to bolster market growth. The increasing prevalence of surgical procedures is anticipated to drive the demand for medical robots between 2014 and 2022.

The growing acceptance of assistive and rehabilitation systems for physical therapy, particularly in the treatment of stroke and motor disability-related neurological disorders, is poised to fuel growth. As disease treatment methods gain prominence, the number of patients treated by medical robots is on the rise. The non-medical hospital products segment is projected to be the fastest growing, with a forecasted CAGR of 16.8%. Factors such as institutional centralization and the expanding healthcare IT market contribute to the increased demand for medical robotic systems.

Global Autonomous Therapy System Market Segmentation: By Application:

• Neurology
• Orthopedics robotic systems
• Laparoscopy
• Special Education
• Others

Segmented into neurology, orthopedics, laparoscopy, and others, robotic systems find applications in various medical fields. The neurology segment is anticipated to experience the fastest growth, with a CAGR of 16.7% during this period, attributed to the global rise in neurological disorders like Alzheimer's disease and depression. Advances in the hardware and software of systems like NeuroMate, coupled with improved ergonomics and neuroscience in robotic neurotechnology, are expected to lead to widespread adoption.

Laparoscopy dominated the application segment in 2014 with a CAGR of 12.3%. The development of new systems with enhanced maneuverability, magnification, and device manipulation, along with improved micro-motions during surgical procedures, is projected to enhance accuracy. The market's growth is further driven by the increasing geriatric population, rising demand for endoscopic diagnostic and therapeutic procedures, and the prevalence of unhealthy lifestyle habits.

Orthopedic robotic systems are expected to be the second-fastest application segment, with a projected CAGR of 14.2% from 2015 to 2022. Growth in software for procedures such as total hip arthroplasty (THA), total knee arthroplasty (TKA), and ACL knee reconstruction is stimulating the demand for minimally invasive robotic surgery.

Global Autonomous Therapy System Market Segmentation: By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East
• Africa

Geographically, North America held the majority share in medical robotic systems with 49.7% in 2014, while Asia-Pacific is anticipated to be the fastest-growing region with a forecasted CAGR of 15.6%. The increasing geriatric population, coupled with issues like low bone density and accidental injuries, is expected to positively impact North America's market growth.

Asia-Pacific is poised for rapid growth, benefiting from emerging opportunities, enhanced healthcare infrastructure, and increased disease awareness. The region's market is driven by the growing penetration of minimally invasive surgeries and the introduction of technologies like capsule robotic systems and advanced imaging systems.

The European market for medical robotic systems is expected to follow the Asia-Pacific market, with a projected CAGR of 11.7% from 2015 to 2022. Rapid changes in surgical procedures, transitioning towards robotic surgeries, and efficient procedures with reduced health risks contribute to the market's growth in Europe.

Key Players:

• MAKO Surgical Corp
• Renishaw Plc.
• Varian
• Accuray
• Intuitive Surgical Inc
• Health robotics S.R.L.

Recent Developments in the Autonomous Therapy System Market:

In recent times, market participants have been implementing strategies to augment their market share by expanding their presence into untapped economies, thereby enhancing their profit potential. Moreover, major corporations are introducing new products to sustain their competitive advantage, thereby bolstering the overall market.

High entry barriers characterize developed economies like North America and Europe in contrast to developing economies such as Asia-Pacific. The Asia-Pacific region, with its low barriers to entry and promising market opportunities, is anticipated to exhibit accelerated growth from 2022 to 2030.

Suppliers are actively investing in research and development endeavors to create technologically advanced systems, gaining a competitive edge and contributing to the industry's economic prosperity. Anticipated in the coming years are multiple mergers and acquisitions within the industry, as companies take proactive measures to secure market share and offer a diverse product portfolio.

Significant Events in the Recent History of the Autonomous Therapy System Market:

Product Launch: In April 2021, Epic and OCHIN jointly launched the COVID-19 Preparedness Screening app. This initiative aimed to enhance interoperability, care coordination, and overall clinical readiness in the state of Washington, US.

Collaboration: In April 2020, Cerner extended its collaboration with Tenet Healthcare Corporation, strategically utilizing Cerner’s IT solutions across Tenet’s hospitals to actively engage patients and providers.